Russell Investments Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
138,941
+12,458
+10% +$972K 0.01% 900
2025
Q4
$9.98M Buy
126,483
+32,381
+34% +$2.8M 0.01% 909
2025
Q3
$8.62M Sell
94,102
-72,845
-44% -$5.94M 0.01% 976
2025
Q2
$10.9M Sell
166,947
-18,528
-10% -$1.21M 0.01% 810
2025
Q1
$12.4M Buy
185,475
+44,979
+32% +$2.69M 0.02% 737
2024
Q4
$7.77M Sell
140,496
-17,462
-11% -$1M 0.01% 940
2024
Q3
$9.42M Buy
157,958
+54,953
+53% +$3.35M 0.01% 862
2024
Q2
$6.56M Sell
103,005
-3,670
-3% -$238K 0.01% 1017
2024
Q1
$7.37M Buy
106,675
+3,027
+3% +$183K 0.01% 978
2023
Q4
$5.72M Sell
103,648
-6,422
-6% -$354K 0.01% 1063
2023
Q3
$6.39M Sell
110,070
-10,724
-9% -$619K 0.01% 970
2023
Q2
$6.5M Buy
120,794
+45,709
+61% +$2.03M 0.01% 972
2023
Q1
$2.98M Sell
75,085
-9,574
-11% -$404K 0.01% 1347
2022
Q4
$3.41M Buy
84,659
+3,446
+4% +$129K 0.01% 1293
2022
Q3
$2.61M Sell
81,213
-7,335
-8% -$251K 0.01% 1404
2022
Q2
$2.63M Hold
88,548
0.01% 1438
2022
Q1
$2.49M Sell
88,548
-6,106
-6% -$228K ﹤0.01% 1526
2021
Q4
$4.36M Sell
94,654
-18,975
-17% -$815K 0.01% 1335
2021
Q3
$3.73M Sell
113,629
-8,770
-7% -$273K 0.01% 1425
2021
Q2
$4.29M Sell
122,399
-51,566
-30% -$1.75M 0.01% 1447
2021
Q1
$6.29M Sell
173,965
-59,114
-25% -$1.85M 0.01% 1224
2020
Q4
$6.77M Buy
233,079
+37,629
+19% +$1.08M 0.01% 1077
2020
Q3
$5.51M Buy
195,450
+95,321
+95% +$2.84M 0.01% 1077
2020
Q2
$3.22M Sell
100,129
-31,383
-24% -$1.13M 0.01% 1356
2020
Q1
$5.35M Buy
131,512
+16,310
+14% +$867K 0.01% 914
2019
Q4
$7.1M Buy
115,202
+18,760
+19% +$1.24M 0.01% 1013
2019
Q3
$7.03M Buy
+96,442
New +$7.22M 0.01% 1023
2019
Q1
Sell
-999
Closed -$45K 2907
2018
Q4
$45K Sell
999
-308
-24% -$16.1K ﹤0.01% 2807
2018
Q3
$74K Buy
1,307
+555
+74% +$34K ﹤0.01% 2792
2018
Q2
$50K Buy
+752
New +$46.9K ﹤0.01% 2805

Other funds holding ANIP